Chad Ingulsrud

Chad Ingulsrud is currently serving as the Finance and Strategic Operations Lead at Merakris Therapeutics, Inc. Previously, Chad worked as a Consultant at Syneos Health and as an Advisor at Isosceles Pharmaceuticals and Rex Health Ventures. Chad holds an MBA from UNC Kenan-Flagler Business School with concentrations in Finance and Healthcare. Before transitioning into the finance sector, Chad worked as a Technology Commercialization Consultant at NC SBTDC, an Image Analyst at Invicro, and a Technologist at Medtox Laboratories. Chad's education background includes a Bachelor's degree in Biology and Philosophy from Concordia College.